scholarly article | Q13442814 |
P356 | DOI | 10.1002/EJI.201242523 |
P698 | PubMed publication ID | 22890791 |
P50 | author | Daniel F Legler | Q54858768 |
P2093 | author name string | Eva Singer | |
Markus Bruckner | |||
Denise Dickel | |||
P2860 | cites work | Antigen presentation and T cell stimulation by dendritic cells | Q22255632 |
Activation of Liver X Receptor Sensitizes Human Dendritic Cells to Inflammatory Stimuli | Q63363442 | ||
Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions | Q74179201 | ||
Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin | Q77995830 | ||
CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2 | Q24298801 | ||
CCR7 and its ligands: balancing immunity and tolerance | Q24316090 | ||
Prostaglandin E(2) enhances T-cell proliferation by inducing the costimulatory molecules OX40L, CD70, and 4-1BBL on dendritic cells | Q24317518 | ||
Reciprocal regulation of inflammation and lipid metabolism by liver X receptors | Q28202771 | ||
Prostaglandins and leukotrienes: advances in eicosanoid biology | Q28208246 | ||
Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs | Q28217626 | ||
Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion | Q28509130 | ||
Rapid leukocyte migration by integrin-independent flowing and squeezing | Q29620345 | ||
Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors | Q33230925 | ||
Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances. | Q33507471 | ||
PPARgamma and LXR signaling inhibit dendritic cell-mediated HIV-1 capture and trans-infection | Q33628817 | ||
In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells | Q33714400 | ||
PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells | Q34124931 | ||
Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells | Q34141893 | ||
LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression | Q34360087 | ||
9-cis-Retinoic acid (9cRA), a retinoid X receptor (RXR) ligand, exerts immunosuppressive effects on dendritic cells by RXR-dependent activation: inhibition of peroxisome proliferator-activated receptor gamma blocks some of the 9cRA activities, and p | Q34579180 | ||
Genetic deletion of mPGES-1 abolishes PGE2 production in murine dendritic cells and alters the cytokine profile, but does not affect maturation or migration | Q34768912 | ||
The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut | Q34790350 | ||
Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. | Q35553327 | ||
PGE2-induced metalloproteinase-9 is essential for dendritic cell migration | Q36384618 | ||
Dendritic cells in a mature age. | Q36475977 | ||
Fascin1 promotes cell migration of mature dendritic cells. | Q36479671 | ||
Integration of metabolism and inflammation by lipid-activated nuclear receptors | Q37225357 | ||
Mechanisms and consequences of dendritic cell migration | Q37272221 | ||
Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis | Q37463199 | ||
Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses | Q39758426 | ||
CCR7-specific migration to CCL19 and CCL21 is induced by PGE(2) stimulation in human monocytes: Involvement of EP(2)/EP(4) receptors activation | Q39834801 | ||
Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling | Q41330743 | ||
Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. | Q44436559 | ||
Prostaglandin E2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells | Q44576443 | ||
A novel signaling pathway mediates the inhibition of CCL3/4 expression by prostaglandin E2. | Q45119186 | ||
MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. | Q46034364 | ||
The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. | Q47915773 | ||
Liver X receptors regulate dendritic cell phenotype and function through blocked induction of the actin-bundling protein fascin. | Q53574931 | ||
Prostaglandin E2 is a key factor for monocyte-derived dendritic cell maturation: enhanced T cell stimulatory capacity despite IDO | Q57896753 | ||
P433 | issue | 11 | |
P921 | main subject | cell migration | Q189092 |
dendritic cell | Q506253 | ||
P304 | page(s) | 2949-2958 | |
P577 | publication date | 2012-09-26 | |
P1433 | published in | European Journal of Immunology | Q5412727 |
P1476 | title | Converse regulation of CCR7-driven human dendritic cell migration by prostaglandin E₂ and liver X receptor activation | |
P478 | volume | 42 |
Q41818188 | CCR7 Receptor Expression in Mono-MAC-1 Cells: Modulation by Liver X Receptor α Activation and Prostaglandin E 2. |
Q47099855 | Cox-2 inhibition and the composition of inflammatory cell populations during early and mid-time tendon healing |
Q92142218 | E6‑regulated overproduction of prostaglandin E2 may inhibit migration of dendritic cells in human papillomavirus 16‑positive cervical lesions |
Q40548665 | Human Bone Marrow-Derived Mesenchymal Stromal Cells Differentially Inhibit Cytokine Production by Peripheral Blood Monocytes Subpopulations and Myeloid Dendritic Cells. |
Q52728752 | LXR nuclear receptors are transcriptional regulators of dendritic cell chemotaxis. |
Q26824274 | LXR-dependent and -independent effects of oxysterols on immunity and tumor growth |
Q26769924 | MGL Receptor and Immunity: When the Ligand Can Make the Difference |
Q64996233 | Microenvironmental derived factors modulating dendritic cell function and vaccine efficacy: the effect of prostanoid receptor and nuclear receptor ligands. |
Q54968645 | NH36 and F3 Antigen-Primed Dendritic Cells Show Preserved Migrating Capabilities and CCR7 Expression and F3 Is Effective in Immunotherapy of Visceral Leishmaniasis. |
Q58801877 | Nuclear Receptor Nur77 Deficiency Alters Dendritic Cell Function |
Q37452166 | The transcription factor NR4A3 controls CD103+ dendritic cell migration |
Search more.